retatrutide triple agonist gip glp-1 glucagon receptor The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Calling retatrutide a “GLP-3” is

Effects depend on what the individual is targeting: Immediate (after 1 session): Feeling refreshed Light hydration boost Subtle glow 46 sessions: Noticeable skin clarity More even tone Improved radiance Long-term (8+ sessions): Deeper antioxidant effects Stable brightening Better skin texture and vitality Sun exposure, hydration, and sleep also influence outcomes

N., Dhanasekara, C

Whether or not it actually works is unclear as of 2019

This is why fatigue on GLP-1 treatment is often worse than it needs to be - it's not purely a medication side effect, it's partly a sign that the body needs more consistent nutritional support than a suppressed appetite is prompting you to give it

This can lead to intestinal permeability which is often a trigger for autoimmune disorders if not addressed

For starters, I had more energy, which Kunin says is one of the common results of an antioxidant drip